205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.02%
Revenue growth under 50% of ON's 4.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-3.26%
Negative gross profit growth while ON is at 3.75%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.40%
Negative EBIT growth while ON is at 1.82%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.06%
Negative operating income growth while ON is at 1.82%. Joel Greenblatt would press for urgent turnaround measures.
-0.75%
Negative net income growth while ON stands at 1.06%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-0.53%
Negative EPS growth while ON is at 0.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1.07%
Negative diluted EPS growth while ON is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.09%
Dividend growth of 0.09% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
38.46%
OCF growth at 75-90% of ON's 44.98%. Bill Ackman would demand better working capital management or cost discipline.
1040.43%
FCF growth above 1.5x ON's 435.68%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.63%
10Y revenue/share CAGR under 50% of ON's 217.63%. Michael Burry would suspect a lasting competitive disadvantage.
13.51%
5Y revenue/share CAGR under 50% of ON's 39.58%. Michael Burry would suspect a significant competitive gap or product weakness.
19.91%
3Y revenue/share CAGR under 50% of ON's 57.72%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.13%
10Y OCF/share CAGR under 50% of ON's 885.62%. Michael Burry would worry about a persistent underperformance in cash creation.
-1.85%
Negative 5Y OCF/share CAGR while ON is at 56.09%. Joel Greenblatt would question the firm’s operational model or cost structure.
35.56%
3Y OCF/share CAGR under 50% of ON's 230.35%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
227.96%
Below 50% of ON's 1072.12%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.17%
Below 50% of ON's 244.52%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
27.56%
Below 50% of ON's 245.66%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
81.65%
Below 50% of ON's 430.72%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
68.77%
5Y equity/share CAGR at 50-75% of ON's 132.31%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
101.75%
3Y equity/share CAGR similar to ON's 108.28%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
341.28%
Dividend/share CAGR of 341.28% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.61%
Dividend/share CAGR of 99.61% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.84%
3Y dividend/share CAGR of 37.84% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
1.02%
AR growth well above ON's 1.46%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.80%
Inventory growth well above ON's 6.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.26%
Asset growth at 50-75% of ON's 4.06%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.34%
50-75% of ON's 7.27%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
0.03%
We have some new debt while ON reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-1.26%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.95%
We cut SG&A while ON invests at 12.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.